A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CHB / chronic hepatitis B infection

[Related PubMed/MEDLINE]
Total Number of Papers: 71
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CHB  (>> Co-occurring Abbreviation)
Long Form:   chronic hepatitis B infection
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study. HBeAg, HBsAg, HBV, PD-1
2019 ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage. ATM, ATR, HBV
2019 Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States. US
2019 Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection. LSM, M2BPGi
2019 Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection. HBsAg, HBV, NA, NIHR HIC
2019 Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. 5hmC, AFP, AUC, cfDNA, HCC, LC
2019 HBcAg-induced upregulated 4-1BB ligand on B cells contributes to B-cell hyperactivation during chronic hepatitis B infection. 4-1BBL, HBcAg, IL
2019 Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam. HBV, HCWs
2019 Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load. HBV
10  2019 Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up. ETV
11  2019 The Effects of Hepatic Steatosis on the Natural History of HBV Infection. ---
12  2019 The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy. NK
13  2019 The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta-analysis of 24,147 subjects. ALD, CHC, FEMs, HCC, REMs, TM6SF2
14  2019 [Development of a quantitative serum assay of Golgi protein 73 in hepatocellular carcinoma using xMAP technology]. GP73, HCC
15  2018 A non-synonymous polymorphism in NBS1 is associated with progression from chronic hepatitis B virus infection to hepatocellular carcinoma in a Chinese population. DSB, HBV, HCC, NBS1, SNPs
16  2018 Characterization of the hepatitis B virus DNA detected in urine of chronic hepatitis B patients. HBV
17  2018 Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma. AUC-ROC, BHL, CI, CTC, HBV, HCC, LC, NPV, PPV
18  2018 Comprehensive Proteomics Identification of IFN-lamda3-regulated Antiviral Proteins in HBV-transfected Cells. IFN-lamda, ISG
19  2018 Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression InVivo. ASGPR, HBsAg, HBV, LNA, SSO
20  2018 Traditional Chinese Medicine Syndrome Patterns and Their Association with Hepatitis B Surface Antigen Levels during the Natural History of Chronic Hepatitis B Virus Infection. BSBC, HBsAg, HC, LKD, LQD, LRP, PLC, SKD, TCMS
21  2017 A preliminary investigation on single nucleotide polymorphism rs2287622 of bile salt export pump gene in patients with chronic hepatitis C virus infection in Hunan, China. BSEP, CHC, HCV, ORs, SNP
22  2017 Association between mitochondrial DNA content and baseline serum levels of HBsAg in chronic hepatitis B infection. HBsAg, HCC, mtDNA, PBL
23  2017 Association between TLR7 copy number variations and hepatitis B virus infection outcome in Chinese. AHB, CIs, CNVs, HBV, TLR7
24  2017 Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes. ---
25  2017 Evaluation of STAT3 rs1053004 single nucleotide polymorphism in patients with chronic hepatitis B and hepatocellular carcinoma. HBV, HCC, SNP, STAT3
26  2017 High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer. HCC, NK
27  2017 Tenofovir-induced Leukocytoclastic Vasculitis. ITP, LCV
28  2017 The role of peginterferon in nucleos(t)ide-analogue-treated chronic hepatitis B patients: A review of published literature. HBeAg, HBsAg, NA, PEG-IFN
29  2017 Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. ---
30  2016 Association of vitamin D deficiency with hepatitis B virus - related liver diseases. HBV, HC, HCC, LC
31  2016 Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE). NAs
32  2016 Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. CHC, HCC
33  2016 Genetic Variations in XRCC4 (rs1805377) and ATF6 (rs2070150) are not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection. HCC, SNPs
34  2016 Hepatitis B and Risk of Non-Hepatocellular Carcinoma Malignancy. HCC
35  2016 HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy. KIRs
36  2016 In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides. ASO, HBsAg
37  2016 Prevalence and Risk Factors of Gallbladder Polypoid Lesions in a Healthy Population. GB, MS
38  2016 Relationship between platelet parameters and hepatic pathology in patients with chronic hepatitis B infection - a retrospective cohort study of 677 patients. MPV, PDW, PLT
39  2016 Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma. HCC
40  2016 Serum soluble urokinase-type plasminogen activator receptor and interferon-gamma-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B. HBV, IP-10, suPAR
41  2015 A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels. ULN
42  2015 Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study. HBV, LC, LMR, MELD, ROC
43  2015 Distinct quasispecies characteristics and positive selection within the core gene in chronic hepatitis B virus infected child and adult patients. dN, HBeAg, HBV, HLA
44  2015 Expression of PD-L1 on CD4+CD25+Foxp3+ Regulatory T Cells of Patients with Chronic HBV Infection and Its Correlation with Clinical Parameters. AST, PD-1, PD-L1
45  2015 Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-gamma response in chronic and resolved HBV. MSS, RHB, SI
46  2015 Single Nucleotide Polymorphisms in miR-149 (rs2292832) and miR-101-1 (rs7536540) Are Not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection. HBV, HCC, HCV, HIV, SNPs
47  2015 Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent. HBsAg, RNAi
48  2015 The Diagnostic Value of FibroScan in Assessing Significant Liver Fibrosis in Patients with Chronic Hepatitis B. ALT, API, AST, AUROC, FS, LSM, PLT, ROC
49  2014 A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. DCs, HBV, ICS, PBMCs, TCRs, X-S-Core
50  2014 Corrective osteotomy in femoral non-union in drug-induced hypophosphataemic osteomalacia. ---
51  2014 Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen. HBeAg, HBV, IL-1, TLR
52  2014 Effect of hepatitis B virus genotypes on the efficacy of adefovir dipivoxil antiviral therapy. ADV, HBV, IFN-alpha, LAM, PCR
53  2014 Gateway to Care campaign: a public health initiative to reduce the burden of hepatitis B in Haimen City, China. HBV
54  2014 Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma. AUC, cfDNA, DMGs, HC, HCC, LC, OR
55  2014 Variants identified by hepatocellular carcinoma and chronic hepatitis B virus infection susceptibility GWAS associated with survival in HBV-related hepatocellular carcinoma. GWAS, HBV, HCC, SNPs
56  2013 Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma? cccDNA, HBV, HCC, IFN
57  2013 Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment. ALT, AST, CHC, ELISA, HBeAg, HBsAg, HBV, HCs, HCV
58  2012 IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. HBV
59  2012 Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B. NK, TLR
60  2012 Relationship of oxidative stress in hepatitis B infection activity with HBV DNA and fibrosis. CAT, HBsAg, OSI, SH, TAS, TOS
61  2012 Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. ---
62  2011 Interferon-alpha-2a and zinc combination therapy in children with chronic hepatitis B infection. HAI, HBV-DNA, IFN, SR
63  2011 The role of liver fibrosis assessment in the management of patients with chronic hepatitis B infection: lessons learned from a single centre experience. ---
64  2010 Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. ---
65  2008 Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. HBeAg
66  2007 The incidence and evolution of thyroid dysfunction during interferon-alpha therapy in children with chronic hepatitis B infection. IFN-alpha
67  2006 Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. ADV, HRQoL, ICER, IFN, LAM, PEG, RCTs
68  2005 Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients. HBeAg, HBsAg
69  2004 Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. LC, pDC
70  2001 [The use of flow cytometry for the determination of the hepatitis B virus pre-S1 envelop protein binding by human peripheral blood lymphocytes in vitro in the course of recovery]. HBsAg, HBV, PBL
71  1995 Effect of pre-S1 antigen on human lymphocyte proliferative responses. PBMCs